Registration Options

Register for the meeting.

Session Time and Location

Date: Monday, 04/25/2022

Time: 11:00 AM (view in the schedule)

Room: TBD

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Pharmacists learn from various colleagues throughout their training and employment. Time and competing priorities prevent vetting all discussions with a thorough drug information search. Information changes over time. As such, some practices and concerns relevant to neuropsychiatry practice today may be inaccurate or based on an incomplete understanding of the evidence. It is important to periodically re-evaluate our practices to avoid perpetuation of misconceptions. In this session, participants will evaluate evidence-based medicine to clarify whether common ideas heard and shared in practice today are fact, myth or whether the verdict is still out.

Faculty Information and Disclosures

Learning Objectives

  1. Recall evidence to determine if mirtazapine and quetiapine have a dose-related or inverse dose-related response with regard to sedation.
  2. Review the evidence for efficacy of typical and atypical antipsychotics for the treatment of negative symptoms associated with schizophrenia.
  3. Discuss the risks of concomitant use of antidepressants with linezolid or triptans.
  4. Explain evidence for re-titration of lamotrigine and compare to package labeling.

Continuing Education Credit and Disclosures

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.